Article

Optimal Combinations of Biomarkers to Determine AT(N) in the Alzheimer’s Disease 

2020-12-03

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> National Institute on Aging—Alzheimer’s Association (NIA-AA) proposed the AT(N) system based on β-amyloid deposition, pathologic tau, and neurodegeneration, which considered the definition of Alzheimer’s disease (AD) as a biological construct. However, the associations between different AT(N) combinations and clinical stage and progression have been poorly explo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1708d5b8-0bab-5323-bb3a-07869001bc39
DOI: 10.21203/rs.3.rs-118287/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Optimal Combinations of Biomarkers to Determine AT(N) in the Alzheimer’s Disease DOI 10.21203/rs.3.rs-118287/v1Read

Atrophy subtypes and the ATN classification scheme in Alzheimer’s diseaseSemantic proximity Read

Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluidSemantic proximity Read

Performance of Plasma Amyloid β, Total Tau and Neurofilament Light Chain Levels for Alzheimer’s Disease IdentificationSemantic proximity Read

Identification of a simple and novel cut-point based CSF and MRI signature for predicting Alzheimer’s disease progression that reinforces the 2018 NIA-AA research frameworkSemantic proximity Read

Comprehensive evaluation of AT(N) imaging biomarkers for predicting cognitionSemantic proximity Read

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.Semantic proximity Read

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersSemantic proximity Read

AT(N) predicts near-term development of Alzheimer’s disease symptoms in unimpaired older adultsSemantic proximity Read

Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.Semantic proximity Read

Biomarker-based staging of Alzheimer disease: rationale and clinical applicationsSemantic proximity Read

Soluble Amyloid-Beta Isoforms Predict Downstream Alzheimer’s Disease PathologySemantic proximity Read

Harmonization of CSF and imaging biomarkers for Alzheimer’s disease biomarkers: need and practical applications for genetics studies and preclinical classificationSemantic proximity Read